Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death

BMC Neuroscience

Volumn 4, Issue , 2003, Pages

  Zhang, YueMei ^a,c   Lu, XiaoFeng ^c   Bhavnani, Bhagu R ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; ESTRADIOL; ESTROGEN; GLUTAMIC ACID; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; REGULATOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG POTENCY; HIPPOCAMPUS; MOUSE; NERVE CELL DIFFERENTIATION; NEUROMODULATION; NONHUMAN; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; GLUTAMIC ACID; HIPPOCAMPUS; HORSES; MICE; NEURONS; NEUROTOXINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 2642542621     PISSN: 14712202     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2202-4-32     Document Type: Article

References (59)

1. Fonnun F: Glutamate: A neurotransmitter in mammalian brain. J Neurochem 1984, 42:1-11.
2. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-95.
3. Choi DW: Glutamate receptors and the induction of excitotoxic neuronal death. Prog in Brain Res 1994, 100:47-51.
4. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994, 330:613-22.
5. Froissard P, Duval D: Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Intl 1994, 24:485-93.
6. Davis JB, Maher P: Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res 1994, 652:169-73.
7. Behl C, Widmann M, Trapp T, Holsboer F: 17β-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995, 216:473-82.
8. Lezoualc'h F, Skutella T, Widmann M, Behl C: Melatonin prevents oxidative stress-induced cell death in hippocampal cells. Neuroreport 1996, 7:2071-7.
9. Tyurin VA, Tyurina YY, Quinn PJ, Schor NF, Balachandran R, Day BW, Kagan VE: Glutamate-induced cytotoxicity in PC12 pheochromocytoma cells: role of oxidation of phospholipids, glutathione and protein sulfhydryls revealed by bcl-2 transfection. Res Mol Brain Res 1998, 60:270-81
10. Zaulyanov LL, Green PS, Simpkins JW: Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell and Mol Neurobiol 1999, 19:705-18.
11. Nicotera P, Ankarcrona M, Bonfoco E, Orrenius S, Lipton SA: Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv in Neurol 1997, 72:95-101.
12. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 1995, 82:349-352.
13. Subbiah MT, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z: Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993, 77:1095-7.
14. Wilcox JG, Hwang J, Hodis HN, Sevanian A, Stanczyk FZ, Lobo RA: Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. Fertil Steril 1997, 67:57-62.
15. Bhavnani BR, Cecutti A, Gerulath A, Woolever AC, Berco M: Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause 2001, 8:408-19.
16. Berco M, Bhavnani BR: Differential Neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death. J Soc Gynecol Investig 2001, 8:245-254.
17. Behl C, Davis JB, Lesley R, Schubert D: Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-27.
18. Slivka A, Cohen G: Hydroxyl radical attack on dopamine. J Biol Chem 1985, 260:15466-72.
19. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994, 140:256-61.
20. Henderson VW: The epidemilogy of estrogen replacement therapy and Alzheimer's disease. Neurology 1997, 48:S27-S35.
21. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348:429-32.
22. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997, 48:1517-1521. Erratum in: Neurology 1998 Aug; 51(2):654.
23. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC, The Cache County Memory Study Investigators: Hormone replacement therapy and incidence of Alzheimer disease in older women. JAMA 2002, 288:2123-9.
24. Bhavnani BR, Berco M, Binkley J: Equine estrogens differentially prevent neuronal cell death induced by glutamate. J Soc Gynecol Investig 2003, 10:302-328.
25. Bhavnani BR, Lu XiaoFeng: Differential interaction of equine estrogens with recombinant human estrogen receptors alpha (ERα) and beta (ERβ). J Soc Gynecol Investig 2003, 10:298.
26. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT: Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989, 2:1547-1558.
27. Maher P, Davis JB: The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 1996, 16:6394-401.
28. Reid JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6.
29. Shaham S, Shuman MA, Herskowitz I: Death-defying yeast identify novel apoptosis genes. Cell 1998, 92:425-427.
30. Wyllie AH, Kerr JF, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68:251-306.
31. Cohen GM, Sun XM, Fearnhead H, MacFarlane M, Brown DG, Snowden RT, Dinsdale D: Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J Immunol 1994, 153:507-16.
32. Huang P, Robertson LE, Wright S, Plunkett W: High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells. Clin Cancer Res 1995, 1:1005-13.
33. Bai L, Wang J, Yin XM, Dong Z: Analysis of apoptosis. In "Essentials of Apoptosis. A Guide for Basic and Clinical Research" Volume 16. Edited by: Yin XM, Dong Z. Humana Press; 2003:239-251.
34. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggsblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997, 138:863-870.
35. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-6.
36. Peitsch MC, Polzar B, Stephan H, Crompton T, MacDonald HR, Mannherz HG, Tschopp J: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 1993, 12:371-7.
37. Barry MA, Eastman A: Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. Biochem Biophys Res Commun 1993, 32:9129-36.
38. Huang P, Ballal K, Plunkett W: Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis. Cancer Res 1997, 57:3407-14.
39. Behl C, Lezoualc'h F, Trapp T, Widman M, Skutella T, Holsboer F: Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997, 138:101-106.
40. Koh JY, Choi DW: Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 1987, 20:83-90.
41. Li Y, Maher P, Schubert D: Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc Natl Acad Sci USA 1998, 95:7748-53.
42. Olney JW: Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-21.
43. Sagara Y, Dargusch R, Chambers D, Davis J, Schubert D, Maher P: Cellular mechanisms of resistance to chronic oxidative stress. Free Radic Biol Med 1998, 24:1375-89.
44. Butterfield DA: β-amyloid-associated free radical oxidative stress and neurotoxicity: implications from Alzheimer's disease. Chem Res Toxicol 1997, 10:495-506.
45. Greenlund LJ, Deckwerth TL, Johnson EM Jr: Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995, 14:303-15.
46. Pike CJ: Estrogen modulates neuronal Bcl-xL expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 1999, 72:1552-63.
47. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, Kurachi Y: 17β-estradiol inhibits the voltage dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol 1995, 294:625-635.
48. Woolley CS, McEwen BS: Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994, 14:7680-7.
49. Panickar KS, Guan G, King MA, Rajakumar G, Simpkins JW: 17β-estradiol attenuates CREB decline in rat hippocampus following seizure. J Neurobiol 1997, 33:961-7.
50. Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimmers foil death wishes. Cell 1994, 79(2):189-192.
51. Kroemer G, Reed JC: Mitochondrial control of cell death. Nature Med 2000, 6:513-9.
52. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 2001, 15:2922-33.
53. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-6.
54. Li LY, Luo X, Wang X: Endonuclease G in an apoptotic DNase when released from mitochondria. Nature 2001, 412:95-9.
55. Penninger JM, Kroemer G: Mitochondria, AIF and caspases-rivaling for cell death execution. Nat Cell Biol 2003, 5:97-9.
56. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G, Slack RS: Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002, 158:507-17.
57. Xiang J, Chao DT, Korsmeyer SJ: Bax-induced cell death may not require interlukin 1β-converting enzyme-like proteases. Proc Natl Acad Sci USA 1996, 93:14559-14563.
58. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC: Bax directly induces release of cytochrome C from isolated mitochondria. Proc Natl Acad Sci, USA 1998, 95:4997-5002.
59. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976, 3:2303-8.